Yahoo Web Search

Search results

  1. May 17, 2023 · But blood clots became a concern starting in April 2021, when the government put a pause on the J&J shot after six women who received it developed rare blood clots—and one died. All of these cases were reported to the Vaccine Adverse Events Reporting System (VAERS), a national early reporting warning system to detect safety problems with U.S ...

    • 065208055
    • kathy.katella-cofrancesco@yale.edu
  2. Feb 27, 2024 · The Johnson & Johnson vaccine has been linked to an increased risk of rare blood clots combined with low levels of blood platelets, especially in women ages 30 to 49.

  3. Apr 27, 2021 · On April 13, the CDC announced six women between the ages of 18 and 48 had developed a cerebral venous sinus thrombosis (CVST) – a clot in the area of the brain that collects and drains...

  4. Jan 20, 2023 · As with any vaccine, rare adverse events have been reported after COVID-19 vaccination. For example, some people who received the Johnson & Johnson and AstraZeneca vaccines reported blood clots. The condition is known as thrombosis with thrombocytopenia syndrome or TTS.

  5. Jun 6, 2023 · On March 13, 2021, the FDA and CDC paused the use of the J&J vaccine out of concern for an extremely rare clotting disorder, which was first noticed with a similar vaccine made by...

  6. Dec 17, 2021 · Nine deaths have been attributed to TTS following the J&J vaccine, the CDC notes. Previously in a November update, the CDC had said the symptoms of TTS had started between three and 15...

  7. Apr 23, 2021 · Tom Williams Getty Images. Medicine. Earlier this month the U.S. Centers for Disease Control and Prevention recommended a pause in the use of the Johnson & Johnson (J&J) COVID-19 vaccine...

  1. People also search for